Shijiazhuang Sihua Pharmaceutical Group’s Sodium Acetate Ringer’s Injection Has Passed the Evaluation of Quality and Therapeutic Equivalence for Generic Drugs.
Category:
发布时间:2023-05-11
【概要描述】
On May 11, the sodium acetate Ringer’s injection (500 ml) submitted by Shijiazhuang Sihua Pharmaceutical Group was approved by the National Medical Products Administration, having passed the evaluation of quality and therapeutic equivalence for generic drugs. This marks the 25th new product approved for the group so far this year.
On May 11, Sodium Acetate Ringer’s Injection (500 ml), submitted by Shijiazhuang Sihua Pharmaceutical Group, was approved by the National Medical Products Administration and passed the evaluation of quality and therapeutic equivalence for generic drugs. This marks the 25th new product approved for the group so far this year.
According to reports, sodium acetate Ringer’s injection is primarily used to replenish body fluids, regulate electrolyte balance, and correct metabolic acidosis when circulating blood volume is reduced.
To date, Shijiazhuang Sihua Pharmaceutical has had 46 drug varieties comprising 60 dosage forms pass the evaluation of generic drug quality and therapeutic equivalence (or be deemed to have passed such an evaluation).
Keywords:
Recommended News
SERVICE HOTLINE
Address: Shimen Building, No. 8 Xingye Street, Shijiazhuang Economic and Technological Development Zone
Tel.: +86-311-67167130
Email: office@sjzsiyao.com
Mobile site
E code
Non-Commercial (Filing) – 2025-0091